Marshall Wace, LLP Indaptus Therapeutics, Inc. Transaction History

Marshall Wace, LLP

  • $81.7 Billion
  • Q2 2025

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$5.21 - $7.93 $66,583 - $101,345
-12,780 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$7.07 - $14.84 $90,354 - $189,655
12,780 New
12,780 $100,000

Others Institutions Holding INDP

# of Institutions
1
Shares Held
43.9K
Call Options Held
0
Put Options Held
0
View Full List

About Indaptus Therapeutics, Inc.

INDP Quotes by TradingView
  • Ticker INDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 8,258,600
  • Market Cap $21M
  • Description
  • Indaptus Therapeutics, Inc., a pre-clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical oncology candidate is Decoy20 to single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as hepatitis B v...
More about INDP
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email